Fernández-González VC, Hernández-Lozada VH

Language: Spanish
References: 9
Page: 28-33
PDF size: 265.88 Kb.

ABSTRACT

Introduction: Gallbladder adenocarcinoma is a rare condition that usually presents with no symptoms upon presentation and has a poor prognosis. The main known risk factor for the development of adenocarcinoma is the association between chronic inflammation caused by gallstones and because these two entities usually present together it makes it difficult to recognize adenocarcinoma at its early stages. Up to 70% of cases are incidentally found upon examination by the pathologist and present at advance stages with a 5% survival rate at five years. Case presentation: 75-year-old male that presents with a 1-month history of right hypochondrium pain with generalized jaundice and direct bilirubin elevation. A diagnosis of acute on chronic cholecystitis was made with a high suspicious of choledocholithiasis, cholecystectomy by laparoscopy was performed following a endoscopic retrograde cholangiopancreatography (ERCP) intraoperative which found significant biliary dilation and stricture that was managed with placement of a biliary stent. Days after it was reported by the pathologist the incidental finding of gallbladder adenocarcinoma. Conclusion: Gallbladder adenocarcinoma presents in most cases with an advance staging disease. Therapeutic options for these patients are limited because of the lack of research demonstrating the benefits on survival rates, that is why is important that the main therapeutic approach focuses on palliative care measurements and relieved of the obstructive symptoms that often accompany this disease so that we can improve patient life style.

REFERENCES

1. Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol. 2015; 21: 12211-12217. Available in: https://pubmed.ncbi.nlm.nih.gov

2. Miller G, Jarnagin WR. Gallbladder carcinoma. Eur J Surg Oncol. 2008; 34: 306-312. Available in: https://pubmed.ncbi.nlm.nih.gov

3. Shukla SK, Singh G, Shahi KS, Bhuvan, Pant P. Staging, treatment, and future approaches of gallbladder carcinoma. J Gastrointest Cancer. 2018; 49: 9-15. Available in: https://pubmed.ncbi.nlm.nih.gov

4. Furlan A, Ferris JV, Hosseinzadeh K, Borhani AA. Gallbladder carcinoma update: multimodality imaging evaluation, staging, and treatment options. AJR Am J Roentgenol. 2008; 191: 1440-1447. Available in: https://www.ajronline.org

5. Sung YN, Song M, Lee JH, Song KB, Hwang DW, Ahn CS. Validation of the 8th edition of the American Joint Committee on Cancer staging system for gallbladder cancer and implications for the follow-up of patients without node dissection. Cancer Res Treat. 2020; 52: 455-468. Available in: https://pubmed.ncbi.nlm.nih.gov

6. Yamaguchi T, Ishihara T, Seza K, Nakagawa A, Sudo K, Tawada K. Long-term outcome of endoscopic metallic stenting for benign biliary stenosis associated with chronic pancreatitis. World J Gastroenterol. 2006; 12: 426-430. Available in: https://www.ncbi.nlm.nih.gov

7. Domper-Arnal MJ, Simón-Marco MA. Tratamiento endoscópico de las estenosis malignas de la vía biliar: puesta al día y puntos más relevantes para la práctica clínica habitual. Rev Esp Enferm Dig [Internet]. 2016; 108: 568-575. Disponible en: https://scielo.isciii.es/scielo.php

8. Wolpin BM, Mayer RJ. A step forward in the treatment of advanced biliary tract cancer. N Engl J Med. 2010; 362: 1335-1337. Available in: https://pubmed.ncbi.nlm.nih.gov

9. Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 2009; 75: 150-155. Available in: https://pubmed.ncbi.nlm.nih.gov